Retrospective Study in Sarcoma Patients (ReTraSarc)

University Medicine Greifswald

Status: Completed

Conditions: Sarcoma of Bone; Sarcoma of Soft Tissue

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03284320

GISG-14

Details and patient eligibility

About

The objectives of this trial is to evaluate efficacy and safety of treatment with Trabectedin in a large cohort of German patients with soft tissue and bone sarcomas.

Enrollment: 514 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with histologically confirmed soft tissue or bone sarcomas treated with at least one cycle of Trabectedin in any line of therapy.
• Age ≥18years at start of therapy with Trabectedin
• Informed Consent
• Patients already deceased may be included when the treating physician is able to determine the presumptive consent

Exclusion criteria

• No follow-up data available